share_log

HC Wainwright & Co. Reiterates Buy on Biotricity, Maintains $2 Price Target

Benzinga Real-time News ·  Feb 15, 2023 06:08

HC Wainwright & Co. analyst Kevin Dede reiterates Biotricity (NASDAQ:BTCY) with a Buy and maintains $2 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment